Description
Buy 4-MeO-PV9 Online | Guaranteed Discrete Delivery EU
Order High-Purity 4-MeO-PV9 for Laboratory Research
Looking to secure a reliable supply of 4-MeO-PV9 to buy 4-MeO-PV9 online for forensic profiling, mass spectrometry calibration, or neuroreceptor transport assays? As a leading European chemical distributor, we deliver certified, premium-grade 4-Methoxypyrrolidinooctanophenone Crystal synthesized under strict laboratory quality control parameters. When you buy 4-MeO-PV9 online through our encrypted portal, you receive a highly stable analytical reference standard optimized for in vitro testing.
We cater exclusively to all individuals, corporate entities, academic institutions, and contract research organizations (CROs). Whether your project requires you to buy 4-MeO-PV9 online for retail gram quantities or a long-term bulk 4-MeO-PV9 supplier contract, our logistics network ensures consistent purity across every batch.
Technical Specifications & Product Identification Data
-
- Systematic IUPAC Nomenclature: 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one
- Standard CAS Registry Number: 2748590-60-3 (Hydrochloride Salt)
- Molecular Formula: C₁₉H₂₉NO₂ · HCl (Refined Hydrochloride Crystal Form)
- Exact Molar Mass: 339.90 g/mol (Refined HCl Salt variant)
- Physical Presentation: Translucent to off-white large crystal structures or dense powder
- Structural Classification: Pyrrolidinophenone synthetic cathinone derivative featuring a methoxy functional group substitution at the para position and an extended eight-carbon alkyl chain.
Theoretical Pharmacology & Documented Adverse Effects
Before you order 4-MeO-PV9 crystal, note that in vitro transport assays classify it as an exceptionally potent central nervous system stimulant. Mechanistically, it functions as a highly selective dopamine and norepinephrine reuptake inhibitor. Due to the presence of the rigid pyrrolidine ring, it behaves as a pure catecholamine transport blocker, exhibiting negligible affinity for serotonin pathways during comparative analytical modeling.
Exposure triggers intense physiological overstimulation. Documented systemic effects include acute tachycardia, heavy peripheral vasoconstriction, elevated blood pressure, severe appetite suppression, hyperthermia, and involuntary muscle tremors. Forensic profiles warn that extended-chain pyrrolidinophenones pose severe cardiotoxic stress and a high risk of cellular membrane damage if basic handling safeguards fail.
Legal Status & European Regulations
The international legal framework surrounding extended-chain pyrrolidinophenone stimulants is strictly enforced and monitored:
-
- European Union: Closely monitored by the European Union Drugs Agency (EUDA) and blanket-banned across almost all EU Member States. National laws—such as Germany’s NpSG (broad structural group ban) and equivalent narcotic acts in France and the Netherlands—restrict distribution solely to state-authorized scientific installations holding specialized permits.
- United Kingdom: Strictly prohibited under the Psychoactive Substances Act 2016, criminalizing unauthorized production, supply, or importation into British territory.
- Shipping Policy: Orders addressed to private residential zip codes or unauthorized territories will be delivered discreetly at you risk and responsibility
Authorized Research Use & Buyer Disclaimer
This compound is prepared, labeled, and shipped exclusively as an analytical reagent and laboratory reference standard. It is strictly prohibited for human consumption or veterinary use. By placing this item into your cart, Please ensure that you check the legality status of any product you purchase on our website as we cannot be held responsible for it.
Frequently Asked Questions (FAQ)
What are the primary health risks associated with 4-MeO-PV9?
As a highly potent pyrrolidinophenone derivative, exposure to 4-MeO-PV9 carries substantial cardiovascular and neurological risks. Documented adverse reactions include severe hypertensive strain, rapid tachycardia, dangerous core temperature spikes (hyperthermia), mitochondrial dysfunction, and profound psychomotor agitation if strict laboratory containment barriers fail.
How does 4-MeO-PV9 differ structurally from 4-MeO-PV8?
The molecular structure of 4-MeO-PV9 differs from 4-MeO-PV8 by a single carbon extension on its alkyl side chain. While 4-MeO-PV8 features a heptanophenone (seven-carbon) backbone, 4-MeO-PV9 incorporates an octanophenone (eight-carbon) tail, which noticeably increases its lipophilicity and molecular clearance kinetics during comparative assays.
Can this material be used for consumer testing?
No. This compound is synthesized and handled strictly as an analytical reference standard. It is not approved for human or veterinary consumption, and any such application is completely illegal and carries life-threatening health and legal consequences.
